Abstract
The overexpression of the growth factor receptor p185neu/c-erbB-2 has been observed in a number of human adenocarcinomas and is mechanistically linked to neoplastic growth. Monoclonal antibodies raised against extracellular domains of the p185neu/c-erbB-2 receptor oncoprotein have been utilized to inhibit the pathway ofneu-induced tumor development. Our laboratory has demonstrated a direct effect of anti-p185neu/c-erbB2 antibodies which requires receptor ligation. This induced aggregation causes the downmodulation of cell-surface expression and eventual degradation of p185neu/c-erbB-2 protein. In cells transformed by theneu oncogene, the result of antibody-induced p185neu/c-erbB-2 receptor modulation is the reversion of the malignant pheno-type. We are exploiting the direct efficacy of this monoclonal antibody by developing small molecules (peptides and organic mimietics) based on anti-p185neu/c-erbB-2 antibody structure that can mediate similar receptor binding and biological effects.
Similar content being viewed by others
References
Myers, J. N., Kokai, Y., Cohen, J. A., and Greene, M. I. (1988)The Year in Immunology, vol. 5 (Cruse, J. M. and Lewis, R. E., eds.), Karger, Basel, pp. 178–194.
Waldmann, T. A. (1991)Science 252, 1657.
Carrol, A. M. and Greene, M. I. (1988),Antibodies in Radiodiagnosis and Therapy. (Zabutsky, M. R. ed.), CRC Press, Boca Raton, FL, pp. 13–43.
Urban, J. L. and Schreiber, H. (1992)Annu. Rev. Immunol. 10, 617.
Morrison, S. L. (1992)Annu. Rev. Immunol. 10, 239.
Schecter, A. L., Stern, D. F., Vaidyanathan, L., Decker, S. J., Drebin, J. A., Greene, M. I., et al. (1984)Nature 312, 513.
Drebin, J. A., Stern, D. F., Link, V. C., Weinberg, R. A., and Greene, M. I. (1984)Nature 312, 545.
Weiner, D. B., Liu, J., Cohen, J. A., Williams, W. V., and Greene, M. I. (1989)Nature 339, 230.
Ullrich, A. and Schlessinger, J. (1990)Cell 61, 203.
Dobashi, K., Davis, J., Mikami, Y., Freeman, J. K., Hamuro, J., and Greene, M. I. (1991)Proc. Natl. Acad. Sci. USA 88, 8582.
Lupu, R., Colomer, R., Kannan, B., and Lippman, M. E. (1992)Proc. Natl. Acad. Sci. USA 89, 2287.
Holmes, W. E., Sliwkowski, M. X., Akita, R., Henzel, W., Lee, J., Park, J., et al. (1992)Science 256, 1205.
Huang, S. S. and Huang, J. S. (1992)J. Biol. Chem. 267, 11508.
Peles, E., Bacus, S., Koski, R., Lu, H., Wen, D., Ogden, S., et al. (1992)Cell 69, 205.
Falls, D. L., Rosen, K. M., Corfas, G., Lane, W., and Fischbach, G. (1993)Cell 72, 801.
Coussens, L., Yang-Feng, T. L., Liao, Y., Chen, E., Gray, A., McGrath, J., et al. (1985)Science 230, 1132.
Akiyama, T., Sudo, C., Ogawara, H., Toyoshima, K., and Yamamoto, T. (1986)Science 232, 1644.
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J., Wong, S. G., Udove, J., et al. (1989)Science 244, 707.
Maguire, H. C. and Greene, M. I. (1990)Pathobiology 58, 297.
Gullick, W. J. (1990)Int. J. Cancer 5, 55.
Kern, J. A., Schwartz, D., Nordberg, J. A., Weiner, D. B., Greene, M. I., Torney, L., et al. (1990)Cancer Res. 50, 5184.
Cohen, J. A., Weiner, D. B., More, K. F., Kokai, Y., Williams, W. V., Maguire, H. C., et al. (1989)Oncogene 4, 81.
Williams, T., Weiner, D. B., Greene, M. I., and Maguire, H. C. (1991)Pathobiology 59, 46.
DiFiore, P. P., Segatto, O., and Aaronson, S. A. (1991)Meth. Enzymol. 198, 272.
Myers, J. N., Drebin, J. A., Wada, T., and Greene, M. I. (1991)Meth. Enzymol. 198, 277.
Drebin, J. A., Link, V. C., and Greene, M. I. (1988)Oncogene 2, 273.
LeVea, C. M., Myers, J. N., Dougall, W. C., Qian, X., and Greene, M. I. (1993)Receptor, in press.
Drebin, J. A., Link, V. C., Stern, D. F., Weinberg, R. A., and Greene, M. I. (1985)Cell 41, 695.
Shepard, H. M., Lewis, G. D., Sarup, J. C., Fendly, B. M., Maneval, D., Mordenti, J., et al. (1991)J. Clin. Immunol. 11, 117.
Drebin, J. A., Link, V. C., Weinberg, R. A., and Greene, M. I. (1986)Proc. Natl. Acad. Sci. USA 89, 2287.
Drebin, J. A., Link, V. C., and Greene, M. I. (1988)Oncogene 2, 387.
Kumar, R., Shepard, H. M., and Mendelsohn, J. (1991)Mol. Cell. Biol. 11, 979.
Stancovski, I., Hurwitz, E., Leitner, O., Ullrich, A., Yarden, Y., and Sela, M. (1991)Proc. Natl. Acad. Sci. USA 88, 8691.
De Santes, K., Slamon, D., Anderson, S., Shepard, M., Fendly, B., Maneval, D., et al. (1992)Cancer Res. 52, 1916.
Harwerth, I. M., Wels, W., Marte, B. M., and Hynes, N. E. (1992)J. Biol. Chem. 267, 15160.
Brandt, Rauf, P. W., Rackovsky, S., and Pincus, M. R. (1990)Proc. Natl. Acad. Sci. USA 87, 8660.
Wada, T., Myers, J. N., Kokai, Y., Brown, V. I., Hamuro, J., LeVea, C. M., et al. (1990)Oncogene 5, 489.
Riechmann, L., Clark, M., Waldmann, H., and Winter, G. (1988)Nature 332, 323.
Winter, G. and Milstein, C. (1991)Nature 349, 293.
Pluckthun, A. (1991)Methods 2, 88.
Saragovi, H. U., Greene, M. I., Chrusciel, R. A., and Kahn, M. (1992)Bio/Technology 10, 773.
Chothia, C. and Lesk, A. M. (1987)J. Mol. Biol. 196, 901.
Williams, W. V., Kieber-Emmons, T., VonFeldt, J., Greene, M. I., and Weiner, D. B. (1991)J. Biol. Chem. 266, 5182.
Saragovi, H. U., Fitzpatrick, D., Raktabutr, A., Nakanishi, H., Kahn, M., and Greene, M. I. (1991)Science 253, 792.
Wada, T., Qian, X., and Greene, M. I. (1990)Cell 61, 1339.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dougall, W.C., Greene, M.I. Biological studies and potential therapeutic applications of monoclonal antibodies and small molecules reactive with theneu/c-erbB-2 protein. Cell Biophysics 24, 209–218 (1994). https://doi.org/10.1007/BF02789231
Issue Date:
DOI: https://doi.org/10.1007/BF02789231